{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:14:50Z","timestamp":1789690490186,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.kint.2018.08.039","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T04:07:08Z","timestamp":1543205228000},"page":"210-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial"],"prefix":"10.1016","volume":"95","author":[{"given":"Aditi","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Puraswani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Kalaivani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.08.039_bib1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","article-title":"A\u00a0randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome","volume":"93","author":"Gruppen","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.039_bib2","first-page":"1442","article-title":"Randomized controlled trial of mycophenolate mofetil (MMF) versus cyclosporine A (CsA) in children with frequently relapsing nephrotic syndrome [abstract]","volume":"22","author":"Dorresteijn","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib3","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/archdischild-2015-308924","article-title":"Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children","volume":"101","author":"Larkins","year":"2016","journal-title":"Arch Dis Child"},{"issue":"suppl 2","key":"10.1016\/j.kint.2018.08.039_bib5","first-page":"139","article-title":"KDIGO clinical practice guideline for glomerulonephritis","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.039_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/j.ajkd.2013.12.002","article-title":"Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in children","volume":"63","author":"Samuel","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2018.08.039_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10157-014-1030-x","article-title":"Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy","volume":"19","author":"Ishikura","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00467-005-1943-4","article-title":"Long-term results of two unconventional agents in steroid-dependent nephrotic children","volume":"20","author":"Donia","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib9","first-page":"126A","article-title":"Efficacy of levamisole compared to cyclophosphamide and steroid in frequently relapsing minimal change nephrotic syndrome","volume":"12","author":"Sural","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00467-004-1615-9","article-title":"Levamisole in steroid sensitive nephrotic syndrome of childhood: the lost paradise?","volume":"20","author":"Davin","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s004670050307","article-title":"Levamisole therapy in corticosteroid dependent nephrotic syndrome","volume":"11","author":"Bagga","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s11255-012-0241-x","article-title":"Long- and short-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome","volume":"45","author":"Elmas","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib13","first-page":"292","article-title":"Effect of levamisole in steroid-dependent nephrotic syndrome","volume":"4","author":"Madani","year":"2010","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.kint.2018.08.039_bib14","first-page":"153","article-title":"Levamisole therapy as a second-line immunosuppressive agent in corticosteroid-sensitive nephrotic syndrome in children","volume":"14","author":"Al-Ibrahim","year":"2003","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"10.1016\/j.kint.2018.08.039_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13312-014-0419-7","article-title":"Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome","volume":"51","author":"Ekambaram","year":"2014","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.kint.2018.08.039_bib16","first-page":"CD002290","article-title":"Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children","volume":"10","author":"Pravitsitthikul","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2018.08.039_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0140-6736(91)93257-A","article-title":"Levamisole for corticosteroid dependent nephrotic syndrome in childhood","volume":"337","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2018.08.039_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00467-005-2080-9","article-title":"Experience with levamisole in frequently relapsing, steroid dependent nephrotic syndrome","volume":"21","author":"Al Saran","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib19","first-page":"289","article-title":"Randomized, double-blind, placebo-controlled trial of levamisole for children with frequently relapsing\/steroid dependant nephrotic syndrome [abstract]","volume":"4","author":"Weiss","year":"1993","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.ajkd.2003.08.011","article-title":"Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome","volume":"42","author":"Bagga","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2018.08.039_bib21","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00467-007-0617-9","article-title":"Treatment with mycophenolate mofetil and prednisolone for steroid dependent nephrotic syndrome","volume":"22","author":"Afzal","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib22","first-page":"268","article-title":"Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center","volume":"72","author":"Fujinaga","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","article-title":"Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil","volume":"19","author":"Gellermann","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.2011.195","article-title":"Clinical trial of focal segmental glomerulosclerosis in children and young adults","volume":"80","author":"Gipson","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.039_bib25","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/ndt\/gfr572","article-title":"Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome","volume":"27","author":"Gellermann","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.08.039_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000445070","article-title":"The value of monitoring the serum concentration of mycophenolate mofetil in children with steroid-dependent\/frequent relapsing nephrotic syndrome","volume":"132","author":"Tong","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2018.08.039_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/FTD.0000000000000258","article-title":"Mycophenolate mofetil therapy in children with idiopathic nephrotic syndrome: does therapeutic drug monitoring make a difference?","volume":"38","author":"Hackl","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.kint.2018.08.039_bib28","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2215\/CJN.00320116","article-title":"Mycophenolic acid pharmacokinetics and relapse in children with steroid-dependent idiopathic nephrotic syndrome","volume":"11","author":"Tellier","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib29","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00467-016-3400-y","article-title":"Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome","volume":"31","author":"Dehoux","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP58393","article-title":"Th1\/Th2 balance in childhood idiopathic nephrotic syndrome","volume":"58","author":"Kaneko","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/PL00013437","article-title":"Th1\/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome","volume":"14","author":"Stachowski","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib32","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00467-009-1194-x","article-title":"The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome","volume":"24","author":"Shao","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib33","article-title":"Th17\/Treg cell expression in children with primary nephrotic syndrome and the effects of ox-LDL on Th17\/Treg cells","volume":"15","author":"Li","year":"2016","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.kint.2018.08.039_bib34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome","volume":"139","author":"Liu","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2018.08.039_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000350161","article-title":"The role of Th17\/IL-17 in the pathogenesis of primary nephrotic syndrome in children","volume":"37","author":"Wang","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.kint.2018.08.039_bib36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","article-title":"T\u00a0regulatory cell function in idiopathic minimal lesion nephrotic syndrome","volume":"24","author":"Araya","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00467-008-1092-7","article-title":"Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome","volume":"24","author":"Iharada","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3345\/kjp.2016.59.5.205","article-title":"Pathogenesis of minimal change nephrotic syndrome: an immunological concept","volume":"59","author":"Kim","year":"2016","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.kint.2018.08.039_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10157-010-0330-z","article-title":"Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome","volume":"14","author":"Kanai","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib40","first-page":"2755","article-title":"Modulatory effects of levamisole and garlic oil on the immune response of Wistar rats: biochemical, immunohistochemical, molecular and immunological study","volume":"14","author":"Mohamed","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.kint.2018.08.039_bib41","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/ar3835","article-title":"Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus","volume":"14","author":"Eickenberg","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2018.08.039_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.trsl.2015.04.013","article-title":"Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression","volume":"166","author":"Kim","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.kint.2018.08.039_bib43","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/TP.0b013e31819d2032","article-title":"Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells","volume":"87","author":"Demirkiran","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.08.039_bib44","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomized trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2018.08.039_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.kint.2018.08.039_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.039_bib47","unstructured":"World Health Organization. Application tools: growth reference 5-19 years. Available at: www.who.int\/growthref\/tools\/en. Accessed February 18, 2017"},{"key":"10.1016\/j.kint.2018.08.039_bib48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.S2.555","article-title":"National High Blood Pressure Education Program Working Group on\u00a0High Blood Pressure in Children and Adolescents. The fourth\u00a0report on the diagnosis, evaluation and treatment of high\u00a0blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.kint.2018.08.039_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-3083.1976.tb03851.x","article-title":"Isolation of lymphocytes, granulocytes and macrophages","volume":"S5","author":"Boyum","year":"1976","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.kint.2018.08.039_bib50","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10753-012-9496-8","article-title":"CD4(+)CD25(+)CD127 (low\/-) T cells: a more specific Treg population in human peripheral blood","volume":"35","author":"Yu","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.kint.2018.08.039_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/CDLI.8.2.303-313.2001","article-title":"Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and\u00a0phytohemagglutinin stimulation","volume":"8","author":"Baran","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.kint.2018.08.039_bib52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0014-4827(92)90360-K","article-title":"Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells","volume":"201","author":"Petersen","year":"1992","journal-title":"Exp Cell Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381830646X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381830646X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:52:43Z","timestamp":1758761563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381830646X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S008525381830646X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.08.039","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734529925.793553916","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}